Heterozygous TP63 pathogenic variants in isolated primary ovarian insufficiency.
Rachel K VanderscheldenMarta Rodriguez-EscribaSerena H ChanAndrea J BermanAleksandar RajkovicSvetlana A YatsenkoPublished in: Journal of assisted reproduction and genetics (2023)
Our results broaden the spectrum of TP63-related disorders, which now includes sporadic and familial, isolated, and syndromic POI. Genomic variants that impair the transactivation inhibitory domain of the TAp63α isoform are the cause of non-syndromic POI. Additionally, variants affecting only the ΔNp63 isoforms may result in isolated POI. In patients with isolated POI, careful evaluation of genomic variants in pleiotropic genes such as TP63 will be essential to establish a full clinical spectrum and atypical presentation of a disorder.